Search research articles
Contact Us
Filters
Showing results (71-80 of 185) with videos related to
Page
of 19
Sort By:
AIDS (London, England)
|
December 16, 2010
Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml
Stéphanie Haïm-Boukobza, Laurence Morand-Joubert, Philippe Flandre, et al.
European Journal of Gastroenterology & Hepatology
|
November 19, 2020
Real-world efficacy and safety of direct-acting antiviral drugs in patients with chronic hepatitis C and inherited blood disorders
Isaac Ruiz, Slim Fourati, Abdelhakim Ahmed-Belkacem, et al.
The New England Journal of Medicine
|
March 10, 2016
Zika Virus Associated with Meningoencephalitis
Guillaume Carteaux, Marianne Maquart, Alexandre Bedet, et al.
The Journal of Antimicrobial Chemotherapy
|
June 13, 2012
HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs
Slim Fourati, Sidonie Lambert-Niclot, Cathia Soulie, et al.
Viruses
|
September 23, 2022
Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses
Abdelhakim Ahmed-Belkacem, Rabah Redjoul, Rozenn Brillet, et al.
Alimentary Pharmacology & Therapeutics
|
September 4, 2020
Fitness-associated substitutions following failure of direct-acting antivirals assessed by deep sequencing of full-length hepatitis C virus genomes
Slim Fourati, Christophe Rodriguez, Alexandre Soulier, et al.
Journal of Clinical Medicine
|
February 11, 2023
The Relative Contributions of Occupational and Community Risk Factors for COVID-19 among Hospital Workers: The HOP-COVID Cohort Study
Sylvie Bastuji-Garin, Ludivine Brouard, Irma Bourgeon-Ghittori, et al.
Antimicrobial Agents and Chemotherapy
|
February 2, 2011
Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir
Lucile Larrouy, Sidonie Lambert-Niclot, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
July 6, 2012
Risk factors for raltegravir resistance development in clinical practice
Isabelle Malet, Slim Fourati, Laurence Morand-Joubert, et al.
Journal of Hematology & Oncology
|
March 19, 2022
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 185) with videos related to
Sort By:
Page
of 19
AIDS (London, England)
|
December 16, 2010
Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml
Stéphanie Haïm-Boukobza, Laurence Morand-Joubert, Philippe Flandre, et al.
European Journal of Gastroenterology & Hepatology
|
November 19, 2020
Real-world efficacy and safety of direct-acting antiviral drugs in patients with chronic hepatitis C and inherited blood disorders
Isaac Ruiz, Slim Fourati, Abdelhakim Ahmed-Belkacem, et al.
The New England Journal of Medicine
|
March 10, 2016
Zika Virus Associated with Meningoencephalitis
Guillaume Carteaux, Marianne Maquart, Alexandre Bedet, et al.
The Journal of Antimicrobial Chemotherapy
|
June 13, 2012
HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs
Slim Fourati, Sidonie Lambert-Niclot, Cathia Soulie, et al.
Viruses
|
September 23, 2022
Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses
Abdelhakim Ahmed-Belkacem, Rabah Redjoul, Rozenn Brillet, et al.
Alimentary Pharmacology & Therapeutics
|
September 4, 2020
Fitness-associated substitutions following failure of direct-acting antivirals assessed by deep sequencing of full-length hepatitis C virus genomes
Slim Fourati, Christophe Rodriguez, Alexandre Soulier, et al.
Journal of Clinical Medicine
|
February 11, 2023
The Relative Contributions of Occupational and Community Risk Factors for COVID-19 among Hospital Workers: The HOP-COVID Cohort Study
Sylvie Bastuji-Garin, Ludivine Brouard, Irma Bourgeon-Ghittori, et al.
Antimicrobial Agents and Chemotherapy
|
February 2, 2011
Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir
Lucile Larrouy, Sidonie Lambert-Niclot, Charlotte Charpentier, et al.
The Journal of Antimicrobial Chemotherapy
|
July 6, 2012
Risk factors for raltegravir resistance development in clinical practice
Isabelle Malet, Slim Fourati, Laurence Morand-Joubert, et al.
Journal of Hematology & Oncology
|
March 19, 2022
Determinants of SARS-CoV-2 waning immunity in allogeneic hematopoietic stem cell transplant recipients
Mathieu Leclerc, Rabah Redjoul, Anne Le Bouter, et al.
Page
of 19